CliffBio
small molecule

TURQOZ

ETHINYL ESTRADIOL; NORGESTREL

Loss of exclusivity—loss of exclusivity
CompanyLupin →See this company's full patent-cliff portfolio

Drug detail

Brand nameTURQOZ
Active ingredientETHINYL ESTRADIOL; NORGESTREL
Strength0.03MG;0.3MG
Dosage formTABLET
RouteORAL-28
ModalitySmall molecule
FDA approvalJuly 2023
Marketing statusRX

More from Lupin

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.